A multi-center randomized prospective study on the treatment of infant bronchiolitis with interferon α1b nebulization.

A multi-center randomized prospective study on the treatment of infant bronchiolitis with interferon α1b nebulization.

BACKGROUND:The respiratory syncytial virus (RSV) is the main cause of bronchiolitis in infants and interferon (IFN) α is a commercial antiviral drug. The nebulization of IFN α1b could be a viable treatment method. In this study, the therapeutic effects and safety of IFN α1b delivery via nebulization...

Full description

Bibliographic Details
Main Authors: Lina Chen, Mingfang Shi, Quanmin Deng, Wenjun Liu, Qin Li, Piao Ye, Xiahui Yu, Benjin Zhang, Yuxia Xu, Xiaolan Li, Yao Yang, Min Li, Yi Yan, Zhe Xu, Jing Yu, Long Xiang, Xiaojun Tang, Guangping Wan, Qiang Cai, Li Wang, Bo Hu, Liang Xie, Gen Li, Lunyan Xie, Xiaoyun Liu, Chunyan Liu, Li Li, Lijie Chen, Xiaobin Jiang, Yana Huang, Si Wang, Jiang Guo, Yan Shi, Xiaofang Wang, Zhiyong Zhao, Yan Li, Yanru Liu, Qiang Fu, Yan Zeng, Yan Zou, Dingyuan Liu, Deyun Wan, Tao Ai, Hanmin Liu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0228391

Internet

https://doi.org/10.1371/journal.pone.0228391

Similar Items